Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,274 | -61,631 | -37,981 | -31,155 | -11,899 |
| Depreciation Amortization | 5,110 | 19,020 | 23,776 | 8,909 | 4,261 |
| Income taxes - deferred | -1,120 | -1,214 | -1,110 | -246 | -133 |
| Accounts receivable | 16,431 | -23,251 | -7,874 | -12,781 | -4,524 |
| Accounts payable and accrued liabilities | -408 | 550 | -374 | -272 | -658 |
| Other Working Capital | 16,759 | -117,634 | -45,924 | -48,308 | -9,791 |
| Other Operating Activity | -4,401 | 82,522 | 45,992 | 49,251 | 18,313 |
| Operating Cash Flow | $7,097 | $-101,638 | $-23,495 | $-34,602 | $-4,431 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 71,700 | 130,165 | 114,031 | 92,675 | 32,445 |
| PPE Investments | -5,194 | -22,569 | -17,589 | -11,542 | -4,716 |
| Net Acquisitions | -55,567 | 3,775 | 3,775 | N/A | N/A |
| Investing Cash Flow | $10,939 | $111,371 | $100,217 | $81,133 | $27,729 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -564 | -870 | -782 | -694 | -606 |
| Common Stock Issued | 9 | 1 | N/A | N/A | N/A |
| Common Stock Repurchased | -44,278 | -13,920 | -13,473 | -13,116 | -10,566 |
| Financing Cash Flow | $-44,833 | $-14,789 | $-14,255 | $-13,810 | $-11,172 |
| Exchange Rate Effect | 3 | 105 | 30 | 15 | 11 |
| Beginning Cash Position | 50,328 | 55,279 | 55,279 | 55,279 | 55,279 |
| End Cash Position | 23,534 | 50,328 | 117,776 | 88,015 | 67,416 |
| Net Cash Flow | $-26,794 | $-4,951 | $62,497 | $32,736 | $12,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,097 | -101,638 | -23,495 | -34,602 | -4,431 |
| Capital Expenditure | -5,202 | -22,574 | -17,594 | -11,544 | -4,718 |
| Free Cash Flow | 1,895 | -124,212 | -41,089 | -46,146 | -9,149 |